Amoxicillin is an antibiotic which specifically treats bacterial infections. Amoxicillin comes under the Penicillin category of antibiotics, under the class of Beta Lactam and Amino Penicillin. It is a widely prescribed and used antibiotics, generally given with the combination of Clavulanic Acid. As per the World Health Organization (WHO), Amoxicillin and Amoxicillin in combination with Clavulanic Acid are the most frequently used antibiotics globally. Amoxicillin is used in a number of bacterial infections, such as, respiratory tract infections, middle ear infections, pneumonia, urinary tract infections, skin infections, and dental infections. It works on the principle of inhibiting the growth of bacterial wall synthesis. Amoxicillin is prescribed mostly to children for antibacterial purposes and should be avoided in patients allergic to Penicillin.
Rise in prevalence of infectious diseases and growing awareness of various diseases and their treatment are the major factors contributing to the growth of the global Amoxicillin market. According to the WHO, in 2013, pneumonia was responsible for one-fifth of the deaths among children globally and around 1.1 million children die due to pneumonia every year. In every 30 seconds, a child of less than five years of age dies due to pneumonia in the world. According to the National Kidney Foundation, urinary tract infection is second highly common infection globally and women are more prone to it. According to the Foundation, around 30 million adults suffer from chronic kidney diseases. Furthermore, rise in awareness regarding various infectious diseases and their treatment is propelling the growth of the global Amoxicillin market. Special regulatory provisions and higher efficacy of Amoxicillin toward urinary tract infections and upper and lower respiratory infections are the other key factors driving the global Amoxicillin market. However, growing antibiotic resistance and slow registration process of national regulation authorities are anticipated to affect the growth of the global Amoxicillin market during the forecast period.
The global Amoxicillin market can be segmented based on dosage form, indication, distribution channel, and region. In terms of dosage form, the global Amoxicillin market can be classified into capsule, tablet, and suspension. The tablet segment dominates the Amoxicillin market and is expected to retain its position during the forecast period owing to low cost of the tablet as compared to that of the other oral dosage forms, storage convenience as tablet form does not require refrigeration and ease of administration being unit dosage form. On the basis of indication, the global Amoxicillin market can be divided into respiratory tract infection, skin infection, chest infection, ear infection, urinary tract or kidney infection, bacterial endocarditis, and others. Respiratory tract infection is expected to dominate the market due to rise in prevalence of respiratory diseases, such as, pneumonia among children and efficacy of Amoxicillin against this disease. In terms of distribution channel, the global Amoxicillin market can be categorized into hospital pharmacies, retail pharmacies, and online pharmacies. Retail pharmacies held a major share of the market due to their easy access and wide availability across regions.
In terms of regions, the global Amoxicillin market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global Amoxicillin market, followed by Europe. Rise in prevalence of respiratory infections, increase in awareness regarding bacterial infections and antibiotics, and presence of major players are likely to drive the Amoxicillin market in North America. The Amoxicillin market in Asia Pacific is expected to expand at a significant CAGR in the near future due to improved supply of the drug by major players and high growth in population in emerging countries, such as, Japan, China, and India.
The global Amoxicillin market is highly competitive and fragmented due to the large number of companies operating in the market. Key players operating in the global Amoxicillin market include CSPC Pharmaceutical Group Limited, GlaxoSmithKline plc, Merck KGaA, NCPC Xianati, Sandoz AG, Sinopharm Weiqida, Sun Pharmaceuticals Industries Limited, Teva Pharmaceuticals USA, Inc., United Laboratories, and DAEWOONG CO.LTD.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.